Key result
Biodegradable PFO occluders show early promise but lack definitive long-term evidence for preventing stroke.
Why the study?
Biodegradable occluders may benefit younger patients or those needing future left-sided interventions, but long-term data and definitive evidence of reduced late complications or improved stroke prevention are lacking.
Do biodegradable devices for transcatheter patent foramen ovale closure improve long-term outcomes and reduce late complications in patients requiring PFO closure?
Do biodegradable devices for transcatheter patent foramen ovale closure improve long-term outcomes and reduce late complications in patients requiring PFO closure?
Biodegradable PFO occluders show early promise for younger patients, but long-term comparative studies are needed to establish their efficacy and safety over traditional devices.
Clinicians should not yet adopt biodegradable occluders routinely; leaves open long-term reductions in complications or better stroke prevention.
Biodegradable occluders may be valuable for younger patients or those who may need future left-sided interventions. Early results are promising, but long-term clinical data are limited, and definitive evidence of reduced late complications or better stroke-prevention outcomes is still lacking. Further optimization of materials, standardized imaging endpoints, and long-term comparative studies remain priorities.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2026) studied this question. Biodegradable patent foramen ovale occluders show promising early results, but definitive long-term evidence of reduced late complications or improved stroke prevention remains lacking.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: